Memorial Sloan Kettering radiation oncologist Christopher Barker

Christopher A. Barker, MD

Radiation Oncologist

Titles

Vice-Chair, Clinical Research, Department of Radiation Oncology

Clinical Expertise

Skin Cancer (Melanoma, Squamous Cell Carcinoma, Basal Cell Carcinoma, Merkel Cell Carcinoma, Dermatofibrosarcoma Protuberans, Cutaneous Angiosarcoma, Kaposi Sarcoma); Keloid Scar; Eye Cancer; Breast Cancer; Lymphoma

Share

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Monday through Friday, 8:00 a.m. to 6:00 p.m., (Eastern time)
Accepted Insurance Providers

Dr. Barker accepts the following list of insurance providers. Select your insurance provider to see more details.

Aetna

Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant

Aetna Medicare Advantage (City of NY retirees only, starting 7/1/23)

Payor Type:
In Network Coverage Type(s): PPO

Blue Cross Blue Shield Federal Employee Program

Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO

Blue Cross Blue Shield New York

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO

Blue Cross Blue Shield states outside of NY/NJ

Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS

Blue Cross Health Plus

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Carrum Health

Payor Type: Commercial
In Network Coverage Type(s): Supplemental

Cigna

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO

Connecticare

Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO

Emblem

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO

Emblem Essential

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Emblem Medicare Advantage

Payor Type:
In Network Coverage Type(s): PPO, HMO

Empire Blue Cross Medicare Advantage

Payor Type:
In Network Coverage Type(s): PPO, HMO, DSN

Empire Essential

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Empire Plan / NYSHIP (Blue Cross/UnitedHealthcare split plan)

Payor Type: Commercial
In Network Coverage Type(s): PPO

Fidelis

Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO

Fidelis Managed Medicaid & HARP

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Fidelis Medicare Advantage

Payor Type:
In Network Coverage Type(s): HMO

First Health

Payor Type:
In Network Coverage Type(s): PPO

Healthfirst

Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS

Healthfirst Managed Medicaid

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Healthfirst Medicare Advantage

Payor Type:
In Network Coverage Type(s): HMO, PPO

Healthsmart

Payor Type: Commercial
In Network Coverage Type(s): PPO EPO

Horizon Blue Cross Blue Shield New Jersey (HMO)

Payor Type: Commercial
In Network Coverage Type(s): HMO

Horizon Blue Cross Blue Shield New Jersey (PPO)

Payor Type: Commercial
In Network Coverage Type(s): PPO

Horizon Blue Cross Blue Shield New Jersey Omnia Tier I (EPO)

Payor Type: Commercial
In Network Coverage Type(s): EPO

Horizon Blue Cross Blue Shield New Jersey Omnia Tier II (EPO)

Payor Type: Commercial
In Network Coverage Type(s): EPO

Horizon Medicare Advantage

Payor Type:
In Network Coverage Type(s): PPO, HMO

Husky CT Medicaid

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government

Magnacare

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO

Medicare Part A&B (traditional Medicare)

Payor Type:
In Network Coverage Type(s): Federal Government

Multiplan/Beech Street/PHCS

Payor Type: Commercial
In Network Coverage Type(s): Supplemental

MVP

Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP

Non-Participating Plans with Out of Network Benefits

Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO

NYC Medicare Advantage Plus for City Employees

Payor Type:
In Network Coverage Type(s): TBD

Oscar

Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO

Oxford

Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO

Qualcare

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO

Straight NJ Medicaid

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government

Straight NY Medicaid

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government

Tricare

Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO

UMR

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS

United Healthcare

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO

World Trade Center Health Program (WTC)

Payor Type: Commercial
In Network Coverage Type(s): State Government

Contact and Location

Locations map
Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.

See all locations

About Me

Education

MD, University of Florida

Residencies

Radiation Oncology - Memorial Sloan Kettering Cancer Center

Fellowships

National Cancer Institute; Memorial Sloan Kettering Cancer Center

Board Certifications

Radiation Oncology

I am a board-certified radiation oncologist who specializes in the treatment of skin cancer (including melanoma) and eye cancer with radiation therapy. I am one of a few radiation oncologists in the country who focus on these diseases. I work closely with a dedicated team of experts. We use advanced radiation techniques to deliver the best possible care to our patients. Some of these techniques include superficial x-ray therapy, electronic and radioisotope-based brachytherapy, stereotactic radiosurgery, and proton therapy. At MSK, we strive to come up with the best solution for even the most rare and challenging problems. I have been a member of the MSK team since 2006. I see patients at Memorial Hospital in Manhattan and MSK Westchester

Read more

I am an active biomedical researcher. My goal is to develop more effective cancer treatments using radiation therapy. Prior to joining MSK, I was a Howard Hughes Medical Institute Research Scholar in the Radiation Oncology Branch of the National Cancer Institute. There I developed an interest in combining cancer medicines with radiation therapy to make treatment more effective. Along with my colleagues in the Immunology Program and the Departments of Medicine and Surgery at MSK, I have developed several clinical trials. Many of these combine novel targeted and immune therapies with radiation therapy for different cancers.

Another major goal of my research is to find better ways to protect our patients from potential radiation therapy side effects. To do this, I work closely with the Medical Physics Department. Some of these new techniques are more convenient for our patients because fewer treatment sessions are required. We have several clinical trials in this area.

My research has been supported by the American Society for Radiation Oncology, the Lymphoma Research Foundation, and the National Institutes of Health. I have authored chapters in major medical textbooks as well as peer-reviewed research studies in journals. These include the New England Journal of Medicine, the Journal of Clinical Oncology, the Journal of the National Cancer Institute, Clinical Cancer Research, Radiation Research, and the International Journal of Radiation Oncology, Biology, and Physics.

I teach others about radiation oncology and skin cancer. I frequently give invited presentations on these subjects at national and international meetings.

In the Department of Radiation Oncology, I lead the clinical research program as Director of Clinical Investigation. This program enables the study of cutting-edge radiation treatments for cancers of all types, as well as targeted and immune therapies with radiation therapy. They offer a unique opportunity for our patients in their fight against cancer.

At MSK, we strive to come up with the best solution for even the most rare and challenging problems.

-Dr. Barker

Awards and Honors

  • Castle Connolly: America's Top Doctors (2023)
  • Castle Connolly: New York Magazine Top Doctors (2019-2020)
  • Castle Connolly Top Doctors New York Metro Area (2016-2020)
  • Super Doctors New York Rising Stars

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all External Beam Radiotherapy Service, Manhattan doctors

See all Brachytherapy Service doctors

See all Proton Therapy doctors

Clinical Trials

Research and Publications

Publications on PubMed

Visit PubMed for a full listing of Dr. Barker’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Christopher A. Barker discloses the following relationships and financial interests:

  • Castle Biosciences
    Provision of Services (uncompensated)
  • Regeneron Pharmaceuticals, Inc.
    Provision of Services

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures